Wellbeing Digital Sciences Inc. announced that its wholly owned subsidiary KGK Science Inc. has been awarded an institution wide cannabis research license for their new facility by Health Canada under the Cannabis Act and Cannabis Regulations, allowing the Company to possess cannabis for the purpose of research and development. The Research License greatly reduces the timelines required for conducting cannabis research and facilitates the ability for KGK to apply for cannabis import permits without first having to obtain project-specific research licenses.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +200.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.79M | |
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |
- Stock Market
- Equities
- MEDI Stock
- News Wellbeing Digital Sciences Inc.
- KGK Science Inc. Awards an Institution Wide Cannabis Research License for Their New Facility by Health Canada